113 related articles for article (PubMed ID: 27099385)
1. Thromboprophylaxis and Outcomes for Total Joint Arthroplasty in Congenital Bleeding Disorders: A Single-Center Experience.
Holderness BM; Goto Y; McKernan L; Bernini P; Ornstein DL
Clin Appl Thromb Hemost; 2016 Sep; 22(6):563-8. PubMed ID: 27099385
[TBL] [Abstract][Full Text] [Related]
2. Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis.
Peng HM; Chen X; Wang YO; Bian YY; Feng B; Wang W; Weng XS; Qian WW
Orthop Surg; 2021 Feb; 13(1):260-266. PubMed ID: 33448672
[TBL] [Abstract][Full Text] [Related]
3. Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study.
Perez Botero J; Spoon DB; Patnaik MS; Ashrani AA; Trousdale RT; Pruthi RK
Thromb Res; 2015 Jan; 135(1):109-13. PubMed ID: 25434629
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis.
Heller S; Secrist E; Shahi A; Chen AF; Parvizi J
J Arthroplasty; 2016 Jul; 31(7):1437-41. PubMed ID: 27026644
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
6. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of different duration of thromboprophylaxis in 16,865 hip replacement patients--a real-word, prospective observational study.
Pedersen AB; Sorensen HT; Mehnert F; Johnsen SP; Overgaard S
Thromb Res; 2015 Feb; 135(2):322-8. PubMed ID: 25511580
[TBL] [Abstract][Full Text] [Related]
9. Does thromboprophylaxis cause bleeding after laparoscopic cholecystectomy?
Gundogdu RH; Oduncu M; Bozkirli BO; Yazicioglu MO; Akbaba S
Bratisl Lek Listy; 2017; 118(3):156-159. PubMed ID: 28319411
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
[TBL] [Abstract][Full Text] [Related]
11. Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.
Sadeghi B; Romano PS; Maynard G; Strater AL; Hensley L; Cerese J; White RH
J Hosp Med; 2012; 7(9):665-71. PubMed ID: 23042665
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an Australian teaching hospital.
Pow RE; Vale PR
Intern Med J; 2015 Mar; 45(3):293-9. PubMed ID: 25546267
[TBL] [Abstract][Full Text] [Related]
13. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
14. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
16. Stratifying Venous Thromboembolism Risk in Arthroplasty: Do High-Risk Patients Exist?
Landy DC; Bradley AT; King CA; Puri L
J Arthroplasty; 2020 May; 35(5):1390-1396. PubMed ID: 32057606
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
18. Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
Bouchard-Fortier G; Geerts WH; Covens A; Vicus D; Kupets R; Gien LT
Gynecol Oncol; 2014 Aug; 134(2):228-32. PubMed ID: 24875122
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
20. A mobile compression device compared with low-molecular-weight heparin for prevention of venous thromboembolism in total hip arthroplasty.
Hardwick ME; Pulido PA; Colwell CW
Orthop Nurs; 2011; 30(5):312-6. PubMed ID: 21934585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
